Plant-derived vaccines: an approach for affordable vaccines against cervical cancer (Q37983418)

26 August 2017

Plant-derived vaccines: an approach for affordable vaccines against cervical cancer (English)

1 reference

26 August 2017

cervix uterine cancer

1 reference

based on heuristic

inferred from title

author name string

Mohammad Tahir Waheed

1

1 reference

26 August 2017

Johanna Gottschamel

2

1 reference

26 August 2017

Syed Waqas Hassan

3

1 reference

26 August 2017

Andreas Günter Lössl

4

1 reference

26 August 2017

13 February 2012

1 reference

Human Vaccines & Immunotherapeutics

26 August 2017

1 reference

26 August 2017

8

1 reference

26 August 2017

3

1 reference

26 August 2017

403-406

1 reference

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

26 August 2017

1 reference

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

21 January 2018

1 reference

Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis

21 January 2018

1 reference

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

21 January 2018

1 reference

Papillomaviruses and cancer: from basic studies to clinical application

21 January 2018

1 reference

A novel, broad spectrum therapeutic HPV vaccine targeting the E7 proteins of HPV16, 18, 31, 45 and 52 that elicits potent E7-specific CD8T cell immunity and regression of large, established, E7-expressing TC-1 tumors

21 January 2018

1 reference

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

21 January 2018

1 reference

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

21 January 2018

1 reference

A long way: history of the prophylactic papillomavirus vaccine

21 January 2018

1 reference

The green vaccine: A global strategy to combat infectious and autoimmune diseases

21 January 2018

1 reference

Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants

21 January 2018

1 reference

Plant-based production of biopharmaceuticals

21 January 2018

1 reference

Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plants

21 January 2018

1 reference

Chloroplast-derived vaccines against human diseases: achievements, challenges and scopes.

21 January 2018

1 reference

Solar-powered factories for new vaccines and antibiotics

21 January 2018

1 reference

Plant-made vaccine antigens and biopharmaceuticals

21 January 2018

1 reference

Plants as bioreactors for the production of vaccine antigens.

21 January 2018

1 reference

Production of human papillomavirus type 16 virus-like particles in transgenic plants

21 January 2018

1 reference

Expression of Human papillomavirus type 16 major capsid protein in transgenic Nicotiana tabacum cv. Xanthi

21 January 2018

1 reference

Expression of human papillomavirus type 16 L1 protein in transgenic tobacco plants.

21 January 2018

1 reference

Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization.

21 January 2018

1 reference

Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic

21 January 2018

1 reference

Translational fusion of chloroplast-expressed human papillomavirus type 16 L1 capsid protein enhances antigen accumulation in transplastomic tobacco.

21 January 2018

1 reference

Transplastomic expression of a modified human papillomavirus L1 protein leading to the assembly of capsomeres in tobacco: a step towards cost-effective second-generation vaccines.

21 January 2018

1 reference

Human papillomavirus vaccines in plants

21 January 2018

1 reference

Vaccine farming in Cape Town

21 January 2018

1 reference

Exhaustion of the chloroplast protein synthesis capacity by massive expression of a highly stable protein antibiotic.

21 January 2018

1 reference

The role of heterologous chloroplast sequence elements in transgene integration and expression

21 January 2018

1 reference

Plastid biotechnology: food, fuel, and medicine for the 21st century

21 January 2018

1 reference

Inducible trans-activation of plastid transgenes: expression of the R. eutropha phb operon in transplastomic tobacco.

21 January 2018

1 reference

Heat-stable oral alga-based vaccine protects mice from Staphylococcus aureus infection.

21 January 2018

1 reference

Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond

21 January 2018

1 reference

Plastid expression of a double-pentameric vaccine candidate containing human papillomavirus-16 L1 antigen fused with LTB as adjuvant: transplastomic plants show pleiotropic phenotypes

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.4161/HV.18568

1 reference

26 August 2017

1 reference